-+ 0.00%
-+ 0.00%
-+ 0.00%

COMPASS THERAPEUTICS ANNOUNCES TOVECIMIG DATA ACCEPTED FOR AN ORAL PRESENTATION AT THE ESMO CONGRESS 2026

Reuters·07/17/2026 14:42:41

Please log in to view news